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DMD #406R
Introduction 4-Ipomeanol, [1-(3-furyl)-4-hydroxypentanone] , is a natural cytotoxin first isolated and purified by Boyd et al. in 1972 from Ipomoea batatas (sweet potatoes) infected with the mold Fusarium solani (Boyd and Wilson, 1972a; Boyd et al., 1972b) .
Extensive investigations have demonstrated that 4-ipomeanol is a lung specific toxin in animals, and that its toxicity is initiated through in situ bioactivation catalyzed by cytochrome P450 enzymes (Doster et al., 1978; Durham et al., 1985; Gram, 1989; Boyd, 1977; Larson et al., 1988; Boyd et al., 1982; Buckpitt et al., 1980) . Biodistribution studies of radiolabelled 4-ipomeanol in rats showed that the radioactivity bound to macromolecules of lung and liver could not be removed either by extraction with strong acids or by repeated washes with organic solvents (Boyd and Burka, 1978a) . Covalently bound radioactive metabolites were found in much higher levels in the lungs compared to non-target tissues such as the liver. It was also demonstrated that without prior metabolism 4-ipomeanol was relatively inert and did not bind significantly to tissue components (Boyd et al., 1978a; Buckkpitt et al., 1982a; Boyd et al., 1978b; Slaugther et al., 1983) . These studies suggested that reactive metabolites derived from 4-ipomeanol metabolism bind covalently to proteins, including P450 enzymes. Other studies showed that covalent binding of reactive metabolites of 4-ipomeanol to cellular proteins of the lungs results in pulmonary cytotoxicity, since preclusion of bioactivation resulted in absence of toxicity (Boyd, 1977; Boyd el al., 1978a; Dutcher et al., 1979) . Recently, our group has characterized 4-ipomeanol as a potent mechanism-based inactivator of human hepatic P450 3A4 (K I = 20 µ M) (Alvarez-Diez et al., 2004) . We found that inactivation of DMD #406R 6 other have postulated that the metabolism of 4-ipomeanol by P450 enzymes may occur through oxidation of its furan ring, following a mechanism similar to the bioactivation of other furans (Gram, 1989; Alvarez-Diez and Zheng, 2004; Dalvie et al., 2002) . The major pathways reported for the bioactivation of furan and other furan-containing compounds by P450 enzymes lead to the formation of α,β-unsaturated aldehyde/ketone of dialdehyde reactive metabolites (Dalvie et al., 2002; Kobayashi et al., 1987; Chen et al., 1995; Khojateh-Bakht et al.,1999; Ravindranath et al.,1984; Ravindranath et al.,1985) .
These intermediates are electrophiles which may potentially attack in situ nucleophilic sites of enzymes, inactivating them, or conjugate with glutathione. Glutathione conjugates are commonly secreted in bile (Gibson et al., 1999 and Davis, 1999; Yamaguchi et al., 1992; Poon et al., 1999; Lee, 2002; Jin et al., 1994) . In this study we detected and confirmed that the molecular mass of 4 glutathione conjugates derived from 4-ipomeanol metabolism matches with predicted mass. We also trapped a reactive metabolite of 4-ipomeanol conjugate with glutathione in hepatic microsomal This article has not been copyedited and formatted. The final version may differ from this version. Currently, there is a growing interest of 4-ipomeanol as a potential pro-drug for P450-directed gene therapy of liver and brain cancers (Mohr et al., 2000; Rainov et al., 1998) .
Successful targeting of brain tumors transfected with P450 4B1 has been reported in animal studies (Rainov et al., 1998) . Our findings help to further support the proposed pathway of bioactivation of 4-ipomeanol by P450 enzymes.

Materials and Methods
Materials
Ethyl-β-oxo- 
Synthesis of deuterated 4-ipomeanol
Deuterated 4-ipomeanol was synthesized under anhydrous conditions following a 2-step scheme previously reported for the synthesis of 4-ipomeanol (Boyd et al., 1972b; Boyd et al., 1973) which was previously modified by our group (Alvarez-Diez and Zheng, 2004) .
In this case, d 6 -propylene oxide was used as deuterating agent. Briefly, ethyl-β-oxo-3-furan-propionate (18 mmols) was mixed with a 9.0 molar excess of d 6 -propylene oxide in EtONa solution followed by overnight stirring at room temperature. The mixture was brought to pH 7.0 and was extracted with chloroform. A deuterated furyl-γ-lactone Scientific, Bellefonte, PA) using a mass spectrometer detector. The gradient solvent system used to elute the sample was as previously reported for a sample of 4-ipomeanol Drug-blank bile was also analyzed in a similar manner. The operating potentials used were those that optimized the detection of a mixture of methyl-and hexyl-glutathione conjugates (10 µ g/ml of each conjugate in water) and of their (MH -129) + m/z fragments in LC-MS/MS using MRM and product ion scanning modes. They were determined by manual infusion of the mixture (standard) into the mass spectrometer using a syringe pump.
This article has not been copyedited and formatted. The final version may differ from this version. 
Trapping the reactive metabolites of 4-ipomeanol with glutathione in vitro and detection of the conjugates by LC-MS/MS
This study was aimed to observe whether glutathione conjugates having the postulated mass (491 Da) could be also detected in vitro, in hepatic microsomal samples of rats.
Microsomal incubations were prepared following a method previously described by Buckpitt et al. (Buckpitt, 1980) with some modification. Briefly, 400 µl-incubation mixtures containing rat hepatic microsomes (25 mg protein/ml), glutathione (1.0 mM), 4-ipomeanol (0.5 mM), and NADPH (8.0 mM) were prepared in 0.1 M potassium phosphate buffer. Control incubations lacked NADPH. The samples were incubated for 15 minutes at 37°C in a shaking water bath. The proteins were precipitated by addition of ice-cold ethanol followed by centrifugation for 30 minutes (3000 rpm, 4 0 C), and the supernatant analyzed by LC-MS/MS following a similar method as that reported above.
In this case, a single ion transition (492 363) was monitored. Table 1 . Incorporation of six deuterium atoms in carbons 3, 4 and 5 of 4-ipomeanol alkyl chain was confirmed by the absence of peaks at 1.78, 3.85 and 1.22 ppm, and by the singlet appearing at 1.90 ppm ( Table 1) . One major peak (99% of the total area) with a retention time of 1.7 minutes (capacity factor = 2.4) was 
Results
Synthesis of deuterated 4-ipomeanol
Detection of glutathione conjugates of 4-ipomeanol in bile of rats by LC-MS/MS
A mixture of methyl-and hexyl-glutathione conjugates (1:1 molar ratio) was used as standard to determine the parameters that optimize the detection of the ion pairs: 
Detection of glutathione conjugates of 4-ipomeanol in vitro by LC-MS/MS
The study was conducted to observe whether glutathione conjugates derived from 4-ipomeanol metabolism having the predicted molecular mass could also be detected by LC-MS/MS (MRM scan) in rat hepatic microsomal incubations. 4-Ipomeanol was incubated with rat liver microsomes in the presence or absence of NADPH. Glutathione was added to the incubation system in order to trap reactive metabolites of 4-ipomeanol.
MRM scans from these microsomal incubations (ion transition 492/363 m/z) were acquired (Figure 3a) . A sharp peak is observed having a similar retention time as metabolite M1, observed in the bile sample. As expected, no corresponding peaks were present in the incubation that lacked NADPH (control, Figure 3b ).
Discussion
For the first time, we report the detection of glutathione conjugates of 4-ipomeanol in vivo, in rat bile. , 1999; Ravindranath et al., 1984; Ravindranath et al., 1985) . For example, bioactivation of 3-methylfuran by P450 enzymes produces an unsaturated dialdehyde metabolites, 4-oxo-2-pentenal and 2-methylbutene-1,4 dial (Ravindranath et al., 1984; Ravindranath et al., 1985) . It was postulated that this reactive metabolite may be formed by direct furan ring opening or via an epoxide intermediate. -2-butene-1,4-dial (Chen et al., 1995) .
Furan undergoes similar metabolic activation to cis
This article has not been copyedited and formatted. The final version may differ from this version. Sahali-Sahly et al., 1996) .
In this study we detected in vitro and in vivo glutathione conjugates derived from 4-ipomeanol metabolism which have the predicted masses (isobaric). Our data also indicate that bioactivation occurred in the furan ring moiety. This further supports the bioactivation pathway previously proposed for 4-ipomeanol. We propose here that two furanepoxide regio-isomers, 1 and 2, and an α,β-unsaturated di-aldehyde, 3, (Scheme 2) may be formed from P-450 mediated bioactivation of 4-ipomeanol. The epoxides and the unsaturated di-aldehyde are electrophilic intermediates which could conjugate with the nucleophile glutathione through a S N 2 reaction or by 1,4-addition Michael addition to the double bond, respectively. This would result in 4 glutathione conjugates (4 -7). These four conjugates may also result from conjugation of epoxides 1 and 2 with gluthatione.
Although glutathione could also attack carbons 3 and 5 of the furan epoxide ring producing two potential thio-hemiacetals, these structures are likely unstable. Boyd, 1980) . Two radiolabelled peaks were separated by anion-exchange HPLC in rat microsomal samples of liver and lung incubated with radiolabelled 4-ipomeanol and glutathione. These peaks, unlike 4-ipomeanol, lacked ultraviolet absorbance at 254 nm.
In addition, the 1-keto moiety of these glutathione conjugates was not reduced to alcohol (since their chromatographic profile was different from the profile observed for glutathione conjugates derived from 1,4-ipomeadiol) which suggested their furan rings were no longer intact.
In rat microsomal incubations we observed only one glutathione conjugate derived from 4-ipomeanol metabolism with mass of 492 Da. Earlier studies showed two radiolabelled conjugates in rat microsomal incubations (Buckpitt and Boyd, 1980) . The discrepancies in the results obtained are very unlikely due to ionization problems in the mass spectrometry, since sensitive detection of glutathione conjugates was achieved, especially in the in vitro study. If two conjugates were to be formed in microsomal incubations, their ionization patterns would expect to be similar as shown in the bile. Boyd et al. cytosolic fractions. Although it was claimed that two conjugates were also formed when a heated cytosolic fraction was added, the GST activity was not measured so there is not clear evidence of its complete inactivation. Another possible explanation for the different result obtained is that one of the two radiolabelled compounds observed may be the result of radiolabelling a ctysolic compound. No structural information of the radiolabelled peaks was provided, only their chromatographic profile and the fact that they lack ultraviolet absorbance.
We and others were able to easily synthesize reactive metabolites of 3-methylfuran conjugated with the nucleophilic agent disemicarbazone and used them as model compounds of 4-ipomeanol metabolism (Ravindranath et al., 1984 and unpublished report) . However to date it has not been possible to synthesize reactive metabolites of 4-ipomeanol using similar or other synthetic approaches. It is reasoned that the presence of a ketone group, an electron-withdrawing group, in the aliphatic chain of 4-ipomeanol as compared to the electron-donating aliphatic chain of 3-methylfuran may be responsible for the synthetic difficulties encountered. We could not determine which isomers are responsible for the four peaks observed in the MRM scans since the synthetic metabolites
are not yet available. The amount of glutathione conjugates observed although sufficient for good detection, was well below the amount required for peak collection for NMR analysis and structural identification. LC-MS operated in tandem in conjunction with the stable isotope technique is a highly sensitive tool for detection of very small amount of metabolites (nanogram to picogram levels) (Poon et. al., 1999) . Since the study published by Buckpitt et al. in 1980, no First, the molecular ions monitored matched with the expected molecular weights of the conjugates. Second, the characteristic neutral loss of 129 Da for glutathione conjugates was observed. Third, the isotope abundance ratio of deuterated to non-deuterated peaks was consistent with hat of 4-ipomeanol given to the rats.
In conclusion, LC-MS/MS using MRM, (a selective scanning mode) along with the stable isotope technique made it possible to detect glutathione conjugates derived This article has not been copyedited and formatted. The final version may differ from this version. 
